Hematology Instruments & Reagents – Global Market Trends

The global market for hematology instruments and reagents is projected to increase rapidly, driven by the rising incidence of blood related disorders and robustly growing business of blood donation and collection. Complete blood count is one of the most commonly performed laboratory tests to characterize early disease detection.

Automation, a growing trend in the market, led to global increase in purchase of hematology instruments, which are indispensable diagnostic tools and still sustain a robust position within the world tending trade. They include flow cytometers, coagulation analyzers, and slide strainers. Specialty analyzers are computerized and are extremely specialized machines that confirm the presence, count, and kinds of cellular components in an exceedingly blood sample for sickness detection and follow up. Samples of blood are processed alone or in batches instantly in an exceedingly medical specialty analyzer.

The major driving factors of global hematology analyzers and reagents market are:

• Increasing adoption of machine-driven hematology instruments
• Rising technological advancements
• Integration of basic flow-cytometry techniques in trendy hematology analyzers
• High-throughput hematology analyzers; and
• Development of high-sensitivity point-of-care (POC) hematology testing
• The restraining factors of this market are:
• Cost of the instruments is quite high.
• Low adoption of advanced hematology analyzers and reagents in rising.
• Product recall.
• High competitive market for entrance.
• Lot of time-consuming and stringent policies.

To sum up, the benefits of using automated instruments include ability to report additional parameters in samples, provide more complete information, more accurate measurement of cell morphology, multifocal single instrument that reduces the need for multiple samples, reduced turnaround time for tests and elimination of errors associated with manual cell counts, and faster, accurate, and reliable results. Asia-Pacific ranks as the fastest growing market led by higher risk of blood transfusion transmissible infection in emerging countries with poor health infrastructure and the resulting increased focus on blood donor screening and testing, rise in blood cancer in line with the epidemic spread of various types of cancers worldwide, developing blood banking infrastructure and rapid overall growth in healthcare infrastructure, and supportive diagnostic services as evidenced by the establishment of new high-volume laboratories that deal with difficult blood samples.